Amandine Mathias

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


46 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2011 | 2010 |
In press
 
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple Sclerosis.
Benkert P., Maleska Maceski A., Schaedelin S., Oechtering J., Zadic A., Vilchez Gomez J.F., Melie-Garcia L., Cagol A., Galbusera R., Subramaniam S. et al. Annals of neurology. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_36CDA594E6F2]
 
Towards the quest of CNS-reactive antibodies in MS and autoimmune-mediated neurological syndromes using a new human-induced pluripotent stem cell-derived based platform
Mathias A dans ECTRIMS. October 11-13. Milan- Italy.
[serval:BIB_616F1D92A2D3]
2024
Herpes simplex encephalitis due to a mutation in an E3 ubiquitin ligase.
Bibert S., Quinodoz M., Perriot S., Krebs F.S., Jan M., Malta R.C., Collinet E., Canales M., Mathias A., Faignart N. et al., 2024/05/10. Nature communications, 15 (1) p. 3969. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_63AF76DC891D]
Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5.
Callegari I., Oechtering J., Schneider M., Perriot S., Mathias A., Voortman M.M., Cagol A., Lanner U., Diebold M., Holdermann S. et al., 2024/03/01. Brain, 147 (3) pp. 839-848. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7D17D7B26D32]
 
Exploring the role of brain-derived extracellular vesicles in viral infections: from pathological insights to biomarker potential.
Oberholster L., Du Pasquier R., Mathias A., 2024. Frontiers in cellular and infection microbiology, 14 p. 1423394. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1B76EEA12BB6]
Human stem cell-derived neurons and astrocytes to detect novel auto-reactive IgG response in immune-mediated neurological diseases.
Mathias A., Perriot S., Jones S., Canales M., Bernard-Valnet R., Gimenez M., Torcida N., Oberholster L., Hottinger A.F., Zekeridou A. et al., 2024. Frontiers in immunology, 15 p. 1419712. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_461752E4D09D]
2023
Comprehensive proteomic analysis of JC polyomavirus-infected human astrocytes and their extracellular vesicles.
Oberholster L., Mathias A., Perriot S., Blaser E., Canales M., Jones S., Culebras L., Gimenez M., Kaynor G.C., Sapozhnik A. et al., 2023/12/12. Microbiology spectrum, 11 (6) pp. e0275123. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5E6A065E798E]
Ocrelizumab Impairs the Phenotype and Function of Memory CD8+ T Cells: A 1-Year Longitudinal Study in Patients With Multiple Sclerosis.
Mathias A., Pantazou V., Perriot S., Canales M., Jones S., Oberholster L., Moulin M., Fenwick C., Bernard-Valnet R., Théaudin M. et al., 2023/03. Neurology: Neuroimmunology & Neuroinflammation, 10 (2) pp. e200084. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_53DB58799AAF]
2022
 
Intrinsic blood-brain barrier dysfunction contributes to multiple sclerosis pathogenesis.
Nishihara H., Perriot S., Gastfriend B.D., Steinfort M., Cibien C., Soldati S., Matsuo K., Guimbal S., Mathias A., Palecek S.P. et al., 2022/12/19. Brain, 145 (12) pp. 4334-4348. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FA179A32E58A]
Generation of transgene-free human induced pluripotent stem cells from erythroblasts in feeder-free conditions.
Perriot S., Canales M., Mathias A., Du Pasquier R., 2022/09/16. STAR protocols, 3 (3) p. 101620. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8C8118CBC867]
 
Delayed and recurrent dimethyl fumarate induced-lymphopenia in patients with multiple sclerosis.
Borrelli S., Mathias A., Goff G.L., Pasquier R.D., Théaudin M., Pot C., 2022/07. Multiple sclerosis and related disorders, 63 p. 103887. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_356C04602C66]
Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study.
Renaud C.O., Ziros P.G., Mathias A., Pot C., Sykiotis G.P., 2022/05/21. Antioxidants, 11 (5) p. 1015. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_089F1B91EF05]
SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus Erythematosus.
Humbel M., Bellanger F., Horisberger A., Suffiotti M., Fluder N., Makhmutova M., Mathias A., Du Pasquier R., Fenwick C., Ribi C. et al., 2022. Frontiers in immunology, 13 p. 843059. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_439FE028F29F]
2021
Differentiation of functional astrocytes from human-induced pluripotent stem cells in chemically defined media.
Perriot S., Canales M., Mathias A., Du Pasquier R., 2021/12/17. STAR protocols, 2 (4) p. 100902. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C3E61A00BACB]
 
A human iPSC-derived CNS platform to investigate T cell autoreactivity in multiple sclerosis
Perriot S, Jones S, Begarie D, Canales M, Oberholster L, Theaudin M, Pot C, Mathias A, Du Pasquier R, 2021/10/12. dans MULTIPLE SCLEROSIS JOURNAL.
[DOI][serval:BIB_FA76C5FB9DE7]
 
Multiparametric phenotyping of immune cell dynamics under ocrelizumab: a one-year longitudinal study in MS patients
Mathias Amandine, 2021/10. Multiple Sclerosis Journal.
[DOI][serval:BIB_AE70FC8C938C]
Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis.
Maggi P., Kuhle J., Schädelin S., van der Meer F., Weigel M., Galbusera R., Mathias A., Lu P.J., Rahmanzadeh R., Benkert P. et al., 2021/08/10. Neurology, 97 (6) pp. e543-e553. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6A4C8678004D]
 
Human induced pluripotent stem cells-derived CNS cells to study CNS-reactive autoantibodies in COVID-19 patients with neurological complications
Mathias A, 2021. dans 14th ISNI Congress - November 8-12 - Virtual.
[serval:BIB_7455E48C167C]
 
Multiparametric phenotyping of immune cell dynamics under ocrelizumab: a one-year longitudinal study in MS patients
Mathias A, 2021. dans ECTRIMS. October 13-15. Virtual.
[DOI][serval:BIB_0A4D52910350]
2020
Advancing human induced pluripotent stem cell-derived blood-brain barrier models for studying immune cell interactions.
Nishihara H., Gastfriend B.D., Soldati S., Perriot S., Mathias A., Sano Y., Shimizu F., Gosselet F., Kanda T., Palecek S.P. et al., 2020/12. FASEB journal, 34 (12) pp. 16693-16715. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_08BCD9D52C53]
 
Detection of novel CNS-specific antibodies using hiPSC-derived astrocytes and neurons: a pilot study on autoimmune-mediated neurological syndromes
Mathias A., Perriot S., Jones S., Torcida N., Canales M., Theaudin M., Pot C., Du Pasquier R., 2020/05/22. dans European Academy of Neurology.
[serval:BIB_1B4B3AC5AE7D]
 
Detection of novel CNS-specific antibodies using human induced pluripotent stem cells-derived astrocytes and neurons: a pilot study on autoimmune-mediated neurological syndromes
Mathias A, 2020. dans 6th Congress of the European Academy of Neurology, Virtual.
[DOI][serval:BIB_EBC56026DB8A]
2019
 
Detection of novel CNS-specific antibodies using hiPSC-derived astrocytes and neurons: a pilot study on autoimmune-mediated neurological syndromes
Mathias A, 2019. dans 4th Swiss Federation of Clinical Neuro-Societies congress , October 23-25, Lausanne, Switzerland.
[DOI][serval:BIB_C567287AC0DC]
2018
 
Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines.
Perriot S., Mathias A., Perriard G., Canales M., Jonkmans N., Merienne N., Meunier C., El Kassar L., Perrier A.L., Laplaud D.A. et al., 2018/11/13. Stem cell reports, 11 (5) pp. 1199-1210. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F9677A578D24]
Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis.
Rolf L., Muris A.H., Mathias A., Du Pasquier R., Koneczny I., Disanto G., Kuhle J., Ramagopalan S., Damoiseaux J., Smolders J. et al., 2018/09. Multiple sclerosis, 24 (10) pp. 1280-1287. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FD2BEB7A97DB]
 
Fatal PML associated with FTY therapy: a four-year retrospective longitudinal study of T cell profile of migration to the CNS and JCV-specific responses
Mathias A, 2018. dans Fatal PML associated with FTY therapy: a four-year retrospective longitudinal study of T cell profile of migration to the CNS and JCV-specific responses.
[serval:BIB_BA78F4BAA255]
2017
Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate.
Mathias A., Perriot S., Canales M., Blatti C., Gaubicher C., Schluep M., Engelhardt B., Du Pasquier R., 2017/11. Neurology: Neuroimmunology & Neuroinflammation, 4 (6) pp. e401. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_4147F114C817]
The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes.
Merienne N., Vachey G., de Longprez L., Meunier C., Zimmer V., Perriard G., Canales M., Mathias A., Herrgott L., Beltraminelli T. et al., 2017/09/19. Cell reports, 20 (12) pp. 2980-2991. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_18C9D3A78F11]
 
Increased ex vivo antigen presentation profile of B cells in multiple sclerosis.
Mathias A., Perriard G., Canales M., Soneson C., Delorenzi M., Schluep M., Du Pasquier R.A., 2017/05. Multiple sclerosis, 23 (6) pp. 802-809. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EAF70FDD4B1B]
 
Progressive multifocal leukoencephalopathy in two natalizumab-treated stepsisters: An intriguing coincidence.
Bacchetta F., Mathias A., Schluep M., Du Pasquier R., 2017/02. Multiple sclerosis, 23 (2) pp. 300-303. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EEF4B976E6D4]
EBI2 Expression and Function: Robust in Memory Lymphocytes and Increased by Natalizumab in Multiple Sclerosis.
Clottu A.S., Mathias A., Sailer A.W., Schluep M., Seebach J.D., Du Pasquier R., Pot C., 2017/01/03. Cell reports, 18 (1) pp. 213-224. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C112D80A9534]
2016
 
Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity.
Kuhle J., Barro C., Disanto G., Mathias A., Soneson C., Bonnier G., Yaldizli Ö., Regeniter A., Derfuss T., Canales M. et al., 2016/10. Multiple sclerosis, 22 (12) pp. 1550-1559. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7771D9B4D9CE]
 
Impact of fingolimod treatment on T cell migration to the CNS: a four-year observational study
Mathias A, 2016. dans ECTRIMS. September 14-17. London, UK.
[DOI][serval:BIB_9F0EBD87EB51]
The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patients.
Mathias A., Perriard G., Canales M., Vuilleumier F., Perrotta G., Schluep M., Du Pasquier R., 2016. Neurology: Neuroimmunology & Neuroinflammation, 3 (2) pp. e209. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_84CE6387A332]
2015
 
Fingolimod favors the migration of T cells toward the CNS without interfering with their anti-viral properties
Mathias A, 2015. dans ECTRIMS. October 7-10. Barcelona, Spain.
[DOI][serval:BIB_6B015320CFDF]
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.
Perriard G., Mathias A., Enz L., Canales M., Schluep M., Gentner M., Schaeren-Wiemers N., Du Pasquier R.A., 2015. Journal of Neuroinflammation, 12 p. 119. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6E0A38EB4D79]
2014
 
Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 α-chain (CD11a) in MS patients.
Jilek S., Mathias A., Canales M., Lysandropoulos A., Pantaleo G., Schluep M., Du Pasquier R.A., 2014/06. Multiple sclerosis (Houndmills, Basingstoke, England), 20 (7) pp. 837-842. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_75F2F83A31AE]
 
Innate immune responses in MS: a systematic monocyte and B cell-based study
Mathias A, 2014. dans 12th ISNI Congress - November 9 – 13 Mainz, Germany.
[serval:BIB_945370164C3F]
 
Role of secretory IgA in the mucosal sensing of commensal bacteria
Mathias A., Pais B., Favre L., Benyacoub J., Corthesy B., 2014. Gut Microbes.
[DOI][serval:BIB_C6D3EFC77243]
2013
 
Agglutinating Secretory IgA Preserves Intestinal Epithelial Cell Integrity during Apical Infection by Shigella flexneri.
Mathias A., Longet S., Corthésy B., 2013. Infection and Immunity, 81 (8) pp. 3027-3034. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_180C05B72C99]
 
Increased ex-vivo antigen presentation profile of B cells in multiple sclerosis
Mathias A, 2013. dans MS State of the Art Symposium, Bern, Switzerland.
[serval:BIB_FD3180BD90B3]
 
Nadir of CD11a expression on T lymphocytes of multiple sclerosis patients after two years on natalizumab.
Mathias A, 2013. dans ECTRIMS. October 2-5. Copenhagen, Denmark.
[DOI][serval:BIB_99D551330EEA]
2011
 
Anti-inflammatory properties of secretory IgA on intestinal epithelial cells during infection by Shigella flexneri
Mathias A., Corthesy B., 2011. p. 99 dans Annual Congress SGAI-SSAI, Advances in immunology and allergology: from research to diagnosis and therapy, Allergologie. Peer-reviewed.
[WoS][serval:BIB_4D87148D9978]
 
N-Glycans on secretory component: mediators of the interaction between secretory IgA and gram-positive commensals sustaining intestinal homeostasis.
Mathias A., Corthésy B., 2011. Gut Microbes, 2 (5) pp. 287-293.
[Pmid][serval:BIB_CBA3459AB6CB]
 
Recognition of Gram-positive Intestinal Bacteria by Hybridoma- and Colostrum-derived Secretory Immunoglobulin A Is Mediated by Carbohydrates.
Mathias A., Corthésy B., 2011. Journal of Biological Chemistry, 286 (19) pp. 17239-17247.
[DOI][WoS][Pmid][serval:BIB_F09BBA5067F3]
2010
 
Potentiation of polarized intestinal Caco-2 cell responsiveness to probiotics complexed with secretory IgA.
Mathias A., Duc M., Favre L., Benyacoub J., Blum S., Corthésy B., 2010. Journal of Biological Chemistry, 285 (44) pp. 33906-33913.
[DOI][WoS][Pmid][serval:BIB_A4AEE878D51A]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University